TrialImmunologic research2017

Curcumin improves treatment outcome of Takayasu arteritis patients by reducing TNF-α: a randomized placebo-controlled double-blind clinical trial.

Nan Shao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.